BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38426873)

  • 21. Maternal Pre-Existing Diabetes: A Non-Inherited Risk Factor for Congenital Cardiopathies.
    Ibrahim S; Gaborit B; Lenoir M; Collod-Beroud G; Stefanovic S
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal echocardiographic screening of diabetic pregnancies for congenital heart disease.
    Gladman G; McCrindle BW; Boutin C; Smallhorn JF
    Am J Perinatol; 1997 Feb; 14(2):59-62. PubMed ID: 9259899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal biomarkers for fetal heart failure in fetuses with congenital heart defects or arrhythmias.
    Miyoshi T; Hosoda H; Nakai M; Nishimura K; Miyazato M; Kangawa K; Ikeda T; Yoshimatsu J; Minamino N
    Am J Obstet Gynecol; 2019 Jan; 220(1):104.e1-104.e15. PubMed ID: 30273582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic mechanisms underlying maternal diabetes-associated risk of congenital heart disease.
    Basu M; Zhu JY; LaHaye S; Majumdar U; Jiao K; Han Z; Garg V
    JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of congenital cardiac defects between 11 and 14 weeks' gestation in high-risk patients.
    Weiner Z; Lorber A; Shalev E
    J Ultrasound Med; 2002 Jan; 21(1):23-9. PubMed ID: 11794398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital heart disease screening: which referral factors are most important?
    Fayyaz A; Ahmed W
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):543-7. PubMed ID: 23930868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ramadan Fasting and Maternal and Fetal Outcomes in Pregnant Women with Diabetes Mellitus: Literature Review.
    Kumar S; Diamond T
    Front Endocrinol (Lausanne); 2022; 13():900153. PubMed ID: 35813638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal three-vessel view on sonography: a clue to the diagnosis of congenital heart disease in the fetus.
    Yoo SJ; Lee YH; Cho KS
    AJR Am J Roentgenol; 1999 Mar; 172(3):825-30. PubMed ID: 10063890
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnostic quality of 3Tesla postmortem magnetic resonance imaging in fetuses with and without congenital heart disease.
    Ulm B; Dovjak GO; Scharrer A; Muin DA; Zimpfer D; Prayer D; Weber M; Berger-Kulemann V
    Am J Obstet Gynecol; 2021 Aug; 225(2):189.e1-189.e30. PubMed ID: 33662361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications for fetal echocardiography.
    Small M; Copel JA
    Pediatr Cardiol; 2004; 25(3):210-22. PubMed ID: 15360114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary Evaluation of Fetal Congenital Heart Defects Changes on Fetal-Maternal Heart Rate Coupling Strength.
    Alangari HM; Kimura Y; Khandoker AH
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():251-254. PubMed ID: 30440385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal voluntary exercise mitigates oxidative stress and incidence of congenital heart defects in pre-gestational diabetes.
    Saiyin T; Engineer A; Greco ER; Kim MY; Lu X; Jones DL; Feng Q
    J Cell Mol Med; 2019 Aug; 23(8):5553-5565. PubMed ID: 31211496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fetal echocardiography. The results of a 3-year study].
    Macedo AJ; Ferreira M; Borges A; Sampaio A; Ferraz F; Sampayo F
    Acta Med Port; 1993 Nov; 6 Suppl 1():I9-13. PubMed ID: 8285127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac teratogenicity of trichloroethylene metabolites.
    Johnson PD; Dawson BV; Goldberg SJ
    J Am Coll Cardiol; 1998 Aug; 32(2):540-5. PubMed ID: 9708489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disorders in glucidic metabolism and congenital heart diseases: detection and prevention.
    Passarella G; Trifirò G; Gasparetto M; Moreolo GS; Milanesi O
    Pediatr Cardiol; 2013 Apr; 34(4):931-7. PubMed ID: 23229289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal diagnosis of congenital heart disease.
    Rossiter JP; Callan NA
    Obstet Gynecol Clin North Am; 1993 Sep; 20(3):485-96. PubMed ID: 8278146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retardation of fetal dendritic development induced by gestational hyperglycemia is associated with brain insulin/IGF-I signals.
    Jing YH; Song YF; Yao YM; Yin J; Wang DG; Gao LP
    Int J Dev Neurosci; 2014 Oct; 37():15-20. PubMed ID: 24953263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal echocardiography for early detection of congenital heart diseases.
    Chitra N; Vijayalakshmi IB
    J Echocardiogr; 2017 Mar; 15(1):13-17. PubMed ID: 27530200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why are congenital heart defects being missed?
    van Nisselrooij AEL; Teunissen AKK; Clur SA; Rozendaal L; Pajkrt E; Linskens IH; Rammeloo L; van Lith JMM; Blom NA; Haak MC
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):747-757. PubMed ID: 31131945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basic technique of fetal echocardiography.
    McCurdy CM; Reed KL
    Semin Ultrasound CT MR; 1993 Aug; 14(4):267-76. PubMed ID: 8217262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.